Related Experiment Video
Updated: Feb 22, 2026
09:31
Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
7.7K
Biomedical nanomotors: efficient glucose-mediated insulin release.
Paula Díez1, Berta Esteban-Fernández de Ávila, Doris E Ramírez-Herrera
1Department of Analytical Chemistry, Complutense University of Madrid, E-28040 Madrid, Spain. rvillalonga@quim.ucm.es.
Nanoscale
|September 21, 2017
Summary
Researchers developed an autonomous nanomachine for insulin delivery. This smart device uses ultrasound-propelled nanomotors and glucose-sensing nanovalves for precise, accelerated insulin release, aiding diabetes management.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery Systems
Background:
- Current diabetes management often relies on external insulin delivery methods.
- Developing autonomous, responsive systems for precise therapeutic delivery is a key challenge.
- Nanomaterials offer potential for targeted and controlled drug release.
Purpose of the Study:
- To design an autonomous, glucose-responsive nanomachine for insulin delivery.
- To integrate ultrasound-propelled nanomotors with enzyme-based sensing-effector units.
- To enhance insulin release kinetics using a mobile nanoplatform.
Main Methods:
- Fabrication of gold nanowire (AuNW) nanomotors coupled with mesoporous silica (MS) segments.
- Gating of MS segments with pH-responsive phenylboronic acid (PBA)-glucose oxidase (GOx) nanovalves for insulin loading.
- Utilizing ultrasound (US) propulsion to enhance glucose-triggered insulin release.
Main Results:
- Successful design of insulin-loaded MS-Au nanomotors.
- Demonstrated glucose-induced opening of nanovalves via PBA protonation and pH changes.
- US-driven nanomotors significantly accelerated glucose-triggered insulin release compared to static controls.
Conclusions:
- The developed autonomous nanomachine effectively delivers insulin in response to glucose levels.
- Combining nanomotor locomotion with responsive nanovalves enhances therapeutic delivery efficiency.
- This technology shows significant promise for improved diabetes management strategies.
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.7K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.7K
01:05Insulin Secretory Vesicles
7.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.1K
01:06Oral Hypoglycemic Agents: Glinides
744
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
744
01:16Hormones Regulating Blood Glucose
7.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.3K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.6K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.6K
01:28Insulin: The Receptor and Signaling Pathways
3.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.8K